CTI BioPharma

1 follower


CTI BioPharma (NASDAQ: CTIC) is a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers.

Industries

Headquarters

Stage

Employees

Links

Org chart

Adam R. Craig
President, CEO & Interim Chief Medical Officer

Adam R. Craig

Collapse
Jennifer A. Smith
SVP, Biometrics
James K. Fong
SVP, Commercial Operations
John P. Volpone
SVP, Strategic Operations
Shantha Tyavanagimatt
Senior Vice President Global Pharmaceutical Operations CMC And Early Development